X-linked congenital stationary night blindness (CSNBX) is a hereditary non-progressive retinal disorder, which can appear in two different clinical forms, complete and incomplete, associated with CSNB1 and CSNB2 loci on Xp. We describe a Sardinian family with complete CSNBX and define better the limits of the CSNB1 genetic locus on Xp11.4 through linkage analysis. Haplotype analysis showed two key recombinants, which restrict the CSNB1 locus to a region of about 3 cM limited by markers DSX1068 and DSX6810 respectively. The locus that we describe is included in the CSNB1 locus defined by previous reports referring to the same clinical form of the disease. These results, in addition to other recent mapping reports about families from different geographical areas, confirm the genetic homogeneity of X-linked complete CSNB.
Introduction
X-linked congenital stationary night blindness (CSNBX) is a hereditary non-progressive retinal disorder. The disorder is characterised by normal fundus appearance, decreased visual acuity, myopia, loss of scotopic vision and a negative shaped electroretinogram (ERG). Some authors have suggested that complete and incomplete CSNB may be identical clinical entities, depending on the degree of rod function. However Miyake et al 1 point out that the defect in the rod visual pathway is different in the two forms of CSNB suggesting different clinical conditions. CSNBX clinical heterogeneity fits well with its recently observed genetic heterogeneity, which has been documented by several linkage studies on different families. [2] [3] [4] [5] [6] [7] [8] Moreover, the gene responsible for CSNBX incomplete form was recently cloned and mapped to the CSNB2 locus. 9, 10 Results of these studies are summarised in Figure 1 .
Two CSNBX loci, CSNB1 and CSNB2, were initially mapped on Xp chromosome, proximal to MAOA and MAOB respectively. [2] [3] [4] [5] A third CSNBX locus, described by Bergen et al, 6 was in close linkage with the RPGR gene, which is localised on Xp21.1 and is responsible for some forms of X-linked retinitis pigmentosa (XLRP).
11 These authors suggested CSNBX as an allelic variant of retinitis pigmentosa type 3 (RP3). A novel locus for incomplete CSNBX was recently identified (CSNB4) in a 5 cM region between Mapping of CSNB1 on Xp11.4 C Rozzo et al the retinitis pigmentosa loci RP2 and RP3. 7 Boycott and collaborators recently gave a more precise location for the two loci CSNB1 and CSNB2, associated respectively with complete and incomplete forms of CSNBX.
8 CSNB2 was finely mapped on Xp11.23 8 and the gene CACNA1F, responsible for incomplete forms of CSNBX, was subsequently identified in this locus. 9, 10 CSNB1 was mapped on Xp11.4-p11.3 8 This interval includes the CSNB4 locus, 7 and partially overlaps with the CSNBX locus associated with RP3, 6 excluding, however, the RPGR gene.
In the present work we describe a Sardinian family with complete CSNBX. Linkage analysis allowed us to map the disease locus on Xp11.4 in a region that overlaps with the recently defined CSNB1 locus. Two key recombinants allowed us better to define the limits of this region. Moreover, our results confirm the genetic homogeneity of complete CSNBX.
Methods

Clinical Studies
We identified and examined a CSNBX Sardinian family. This family has been described in a preliminary report. 12 Twentythree family members (Figure 2 ) participated in this study.
On the basis of a family history of long-standing night blindness and of clinical examination six males were found to be affected with CSNBX. All six patients had high myopia (12 diopters or more) with myopic astigmatism (2 diopters or more), nystagmus, low visual acuity (3/10 or less) and normal fundus, except for one case with tilted discs. Two out of six patients had surgically compensated juvenile glaucoma. Dark adaptation curves were monofunctional in all cases, with a normal cone adaptation curve. The electroretinogram showed complete form features, according to criteria established by Miyake et al. 1, 13, 14 In accordance with the Declaration of Helsinki, informed constent was obtained and 10 ml of venous blood were collected from each participating family member for genetic analysis.
Genetic Analysis
Genomic DNA was extracted from whole blood samples using standard 'salting out' procedure. 15 To characterise the locus associated with the disease we performed microsatellite analysis using 15 polymorphic markers covering the cytogenetic regions Xp21.1-p11.4-p11.3. Several reports indicated this region to possibly contain one or more CSNBX genes. [2] [3] [4] [5] 7, 8 The chosen markers were: tel DXS1110, DXS8014, DXS1068, DXS8025, DXS556, DXS8015, DXS8012, DXS993, DXS1368, DXS228, DXS6810, DXS7, MAO-A, MAO-B, DXS1003 cen (Figure 2 ). Microsatellite analyses were performed following standard procedures using specific primers deduced from Genome Database.
Statistical Analysis
Two-point linkage analysis was performed by the MLINK and ILINK routines of Fastlink package v.3.0P. 16 A disease-allele frequency of 0.0001 and equal allele frequencies within each marker system were assumed. Penetrance values for carriers were set at 0.0000. Support for linkage was evaluated by multilocus linkage analysis using the LINKMAP routine of Fastlink, with the following markers: DXS1110, DXS8025, DXS556, DXS8015, DXS8012, DXS6810, MAOB, and DXS1003. The reference genetic map used for the analysis were obtained from Généthon and Marshfield linkage map.
Results
Haplotype analysis detects a common haplotype among all the patients for markers DXS8025, DXS556, DXS8015, DXS8012, DXS993, DXS1368, DXS228 (Figure 2 ). The carrier female IV:6 shows a key recombination, which maps the disease locus proximal to marker DXS1068. The recombination has occurred in the maternal germline as demonstrated by subjects IV:2 and IV:9 carrying the original haplotype. A second key recombination is present in the unaffected male V:18, locating the CSNBX locus distal to marker DXS6810 (Figure 2 ). This locus is therefore distinct from the RP3 locus, which mapped distally to marker DXS1110, 11 and from the RP2 locus, which mapped proximally to MAOB 17, 18 ( Figure 1 ). The highest two-point lod scores of 3.03 and 2.82 were obtained with DXS8025 and DXS556 respectively, at a recombination fraction of q = 0.00. Multipoint analysis was performed with the most informative linked markers to establish a 3-lod support interval: data suggest that the disease locus most likely lies in the interval DXS8025-0.2 cM (CSNB-DXS556)-1.5 cM-DXS8015 with a peak multipoint lod score of 3.56. However, the 3-lod support interval extends within the region between DXS8025 and DXS6810.
Discussion
The short arm of chromosome X is rich in genetic loci associated with retinal disorders. Many of these loci are overlapping and could represent allelic forms of the same gene. [2] [3] [4] [5] [6] [7] [8] 11, 18, 19 However recently physical mapping and sequence analysis revealed a gene-rich area containing novel genes in the proximal portion of Xp. 20 Numerous and accurate genetic studies are necessary better to characterise the genetic differences among all the phenotypically heterogeneous eye diseases mapping to this region.
Mapping of CSNBX genes on Xp was recently better defined. CSNBX incomplete form (CSNB2) was associated with mutations in the CACNA1F gene, a retinaspecific calcium channel α-subunit gene, located in Xp11.23 between DXS722 and DXS255 markers. 9, 10 On the other hand, CSNBX complete form (CSNB1) was mapped on Xp11.4-p11.3. 8 Our clinical and genetic results confirm the CSNB1 map described by Boycott and colleagues 8 and restrict it to Xp11.4. Moreover, our data support the hypothesis that CSNB1 and CSNB2 represent different clinical entities. Our results, together with the recent CSNB1 mapping report, 8 restrict the CSNB1 locus to a region of about 2 cM, between markers DXS6810 and DXS556 (Figure 1) .
Genetic homogeneity for complete CSNBX is supported by the fact that it maps on the same locus in several families of different geographical origin.
However, it is interesting to note that the locus CSNB4 associated with an incomplete form of the disease 7 maps to the same Xp11.4 region as the complete form CSNB1 (Figure 1) . It is therefore possible that two different genes lie close to each other in this region, and they are responsible for complete and incomplete forms. Alternatively, a single gene could be responsible for both forms.
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